-
Posted by
Two Blokes Jul 8 -
Filed in
Stock
-
5 views
Basel, July 8, 2025 – Novartis today announced Coartem\u00ae (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet\u00ae Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.
